These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4555668)

  • 1. Effect of cyclandelate on perception, memory and cognition in a group of geriatric subjects.
    Aderman M; Giardina WJ; Koreniowski S
    J Am Geriatr Soc; 1972 Jun; 20(6):268-71. PubMed ID: 4555668
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclandelate and mental functions: a double-blind cross-over trial in normal elderly subjects.
    Judge TG; Urquhart A; Blakemore CB
    Age Ageing; 1973 May; 2(2):121-4. PubMed ID: 4591604
    [No Abstract]   [Full Text] [Related]  

  • 3. Electroencephalographic study of dose-response relations for cyclandelate on hyperventilation-induced vasospasm in human brain.
    Korenyi C; Whittier JR
    Angiology; 1969 Oct; 20(9):529-34. PubMed ID: 5824354
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of the cerebral manifestations of arteriosclerosis with cyclandelate.
    Young J; Hall P; Blakemore C
    Br J Psychiatry; 1974 Feb; 124(579):177-80. PubMed ID: 4596673
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Cyclandelate and improved brain function.
    Wechsler AF
    Am J Psychiatry; 1974 Jun; 131(6):723. PubMed ID: 4827806
    [No Abstract]   [Full Text] [Related]  

  • 6. Action of cyclandelate on the development of collateral vessels in the rabbit.
    van Hell G
    Curr Med Res Opin; 1974; 2(4):211-7. PubMed ID: 4841308
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of cerebral circulatory drugs on cerebral and peripheral circulation, with special reference to aminophylline, papaverine, cyclandelate and isoxsuprine.
    Miyazaki M
    Eur Neurol; 1971-1972; 6(1):162-5. PubMed ID: 5153420
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of various therapeutic agents on cerebral and peripheral circulation--aminophylline, papaverine, cyclandelate and isoxsuprine].
    Miyazaki M
    Naika; 1972 Mar; 29(3):531-4. PubMed ID: 5035841
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of cerebral circulatory drugs on cerebral and peripheral circulation, with special reference to aminophylline, papaverine, cyclandelate and isoxsuprine.
    Miyazaki M
    Jpn Circ J; 1971 Sep; 35(9):1053-7. PubMed ID: 5172103
    [No Abstract]   [Full Text] [Related]  

  • 10. Trace anesthetic effects on perceptual, cognitive, and motor skills.
    Bruce DL; Bach MJ; Arbit J
    Anesthesiology; 1974 May; 40(5):453-8. PubMed ID: 4595616
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclandelate in long standing cerebral arteriosclerosis.
    Rogers WF; Shaikh VA; Clark AN
    Gerontol Clin (Basel); 1970; 12(2):88-93. PubMed ID: 4987660
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective action of cyclandelate in hypoxia.
    Funcke AB; van Beek MC; Nijland K
    Curr Med Res Opin; 1974; 2(1):37-42. PubMed ID: 4842317
    [No Abstract]   [Full Text] [Related]  

  • 13. Vertebrobasilar arterial insufficiency with dementia. Controlled trials of treatment with betahistine hydrochloride.
    Rivera VM; Meyer JS; Baer PE; Faibish GM; Mathew NT; Hartmann A
    J Am Geriatr Soc; 1974 Sep; 22(9):397-406. PubMed ID: 4212512
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of cyclandelate in chronic brain syndrome with arteriosclerosis.
    Fine EW
    Curr Ther Res Clin Exp; 1971 Sep; 13(9):568-74. PubMed ID: 5000458
    [No Abstract]   [Full Text] [Related]  

  • 15. Specific effects of cyclandelate on memory.
    Ananth J
    Drugs; 1987; 33 Suppl 2():97-102. PubMed ID: 3622311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclandelate on dementia.
    Westreich G; Alter M; Lundgren S
    Stroke; 1975; 6(5):535-8. PubMed ID: 1101457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cyclandelate in depressed and demented patients: a controlled study in psychogeriatric patients.
    Davies G; Hamilton S; Hendrickson E; Levy R; Post F
    Age Ageing; 1977 Aug; 6(3):156-62. PubMed ID: 331919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium modulation and clinical effect. Profile of cyclandelate.
    Timmerman H
    Drugs; 1987; 33 Suppl 2():1-4. PubMed ID: 3622303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperbaric oxygenation and the cognitive functioning of the aged.
    Edwards AE; Hart GM
    J Am Geriatr Soc; 1974 Aug; 22(8):376-9. PubMed ID: 4852322
    [No Abstract]   [Full Text] [Related]  

  • 20. Modes and mechanisms of action of vasoactive drugs and especially of cyclandelate.
    Timmerman H
    Br J Clin Pract Suppl; 1984; 34():10-9. PubMed ID: 6430317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.